FDA warns about eyelash thickener claims

By Cynthia Rowland | September 18, 2009

Allergan Web site is misleading about glaucoma drug risks, agency says The Associated Press NEW YORK – The Food and Drug Administration has warned Allergan Inc. that the Web site for its eyelash thickener Latisse is misleading because it avoids or downplays risks associated with the product. In a letter dated Sept. 10 and posted…

Read More